AngioWaveNet vs prolaio eVO2peak Module

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Angiowave Imaging
VS
by Prolaio

AI Verdict

AngioWaveNet enhances fluoroscopic angiograms to improve vessel visualization in cardiac catheterization laboratories, focusing on imaging clarity. In contrast, the prolaio eVO2peak Module estimates peak oxygen consumption using data from wearable sensors for cardiovascular assessment. While both are FDA-cleared AI tools in cardiology, they address distinct clinical needs: one for image processing and the other for physiological metric estimation.

Choose AngioWaveNet if…

Choose AngioWaveNet if your primary goal is to enhance the clarity and detail of fluoroscopic angiograms directly within your cardiac catheterization lab workflow. This tool is ideal for interventional cardiologists and radiologists seeking improved vessel visualization during procedures, aiding in more precise diagnosis and intervention by clarifying vascular structures and anatomical features.

View AngioWaveNet →

Choose prolaio eVO2peak Module if…

Choose prolaio eVO2peak Module if you need to remotely and longitudinally assess a patient's cardiovascular fitness and functional capacity using real-world data from wearable sensors. This module is best suited for clinicians and researchers focused on risk stratification, rehabilitation monitoring, or general cardiovascular health assessment, providing an estimated peak oxygen consumption as an adjunctive aid in clinical evaluation.

View prolaio eVO2peak Module →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AngioWaveNet prolaio eVO2peak Module
Pricing Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. Unknown
Deployment Cloud-based or on-premise/servers Cloud
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AngioWaveNet

AngioWaveNet is designed to integrate seamlessly with existing Cath lab workflows and is compatible with any fluoroscopic angiography system, functioning as a DICOM endpoint. This vendor-agnostic approach minimizes disruption and simplifies adoption for clinical users. In contrast, prolaio eVO2peak Module relies on data from third-party wearable sensors, which could introduce additional steps and potential complexities in data collection and management for the end-user.

Clinical Value

prolaio eVO2peak Module

Prolaio eVO2peak Module provides a validated estimation of peak oxygen consumption (eVO2peak) using real-world patient data, supported by a multi-center clinical study that met target accuracy and reliability criteria. This offers a quantifiable physiological metric for cardiovascular assessment and longitudinal management. While AngioWaveNet enhances image visualization, it explicitly states that final clinical decisions should be made using original unprocessed angiograms, positioning it more as an aid than a direct diagnostic tool.

Pricing & Value

AngioWaveNet

AngioWaveNet offers transparent pricing options, including annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs, with custom packages available. This clear structure allows potential customers to better understand the investment. Prolaio eVO2peak Module, however, only states 'contact for pricing,' which provides less upfront transparency for assessing value.

Enterprise Readiness

AngioWaveNet

AngioWaveNet offers flexible deployment options (cloud-based or on-premise) and is vendor-agnostic, integrating as a DICOM endpoint with existing Cath lab workflows. These features are crucial for seamless integration into diverse hospital IT environments. Prolaio eVO2peak Module, while cloud-based and compliant, relies on processing data from qualified third-party wearable sensors, which could add complexity for enterprise-wide device management and data standardization.

Innovation

prolaio eVO2peak Module

Prolaio eVO2peak Module demonstrates greater innovation by leveraging diverse real-world data sources, including demographic data, single-lead ECG, and triaxial accelerometry from wearable sensors, combined with a locked deep-learning model to estimate a complex physiological parameter. This approach enables high-density, longitudinal data collection and novel insights into cardiovascular health. AngioWaveNet, while valuable, focuses on enhancing existing angiographic images, which is an improvement in visualization but less fundamentally novel in its data acquisition and synthesis.

Support & Docs

AngioWaveNet

AngioWave Imaging explicitly details comprehensive support, including full onboarding, installation assistance, staff training, and access to ongoing updates and clinical resources. This structured approach is vital for successful implementation and ongoing use in a clinical setting. Prolaio mentions 'Always-on support' and technical support for study participants, but AngioWaveNet's description is more specific regarding enterprise-level support.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AngioWaveNet prolaio eVO2peak Module
Name AngioWaveNet prolaio eVO2peak Module
Company Angiowave Imaging Prolaio
Tagline AI Transforming Angiography Heart care, connected.
Primary Function AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. Software to estimate peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Clinical Decision Support & Reference
Specialties Cardiology, Interventional Radiology, Vascular Surgery Cardiology, Physical Medicine & Rehab, Sports Medicine

Videos

Demos, reviews, and walkthroughs featuring AngioWaveNet and prolaio eVO2peak Module.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AngioWaveNet is designed to enhance fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, aiding in the analysis and interpretation of X-ray coronary angiographic cines. In contrast, the prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) using real-world patient data, serving as an adjunctive aid in the clinical evaluation of patients for cardiovascular research and care.
AngioWaveNet functions as a DICOM endpoint, processing angiographic images from any fluoroscopic angiography system. The prolaio eVO2peak Module utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs, which are collected from qualified third-party FDA-cleared wearable medical sensors.
AngioWaveNet integrates directly with existing Cath lab workflows, processing angiographic cines automatically after acquisition to provide enhanced images. The prolaio eVO2peak Module processes remote sensor data from wearable medical sensors, enabling high-density, longitudinal data collection for cardiovascular assessment.
AngioWaveNet provides improved vessel visualization in fluoroscopic angiograms, enhancing the visibility of blood vessels, vascular structures, and anatomical features. The prolaio eVO2peak Module provides an estimation of peak oxygen consumption (eVO2peak) as an adjunctive aid in clinical evaluation, leveraging real-world patient data and insights.
AngioWaveNet is primarily designed for Cardiology, Interventional Radiology, and Vascular Surgery. The prolaio eVO2peak Module targets Cardiology, Physical Medicine & Rehab, and Sports Medicine.
AI Tool Finder
AI-powered search. Results may not be comprehensive.